Osimertinib with or without chemotherapy - non-small cell lung cancer with EGFR mutations (exon 19 deletion or L858R of exon 21)

被引：0

作者：

Drappier, Noemie ^{[1
]}

Messekher, Merouane ^{[1
]}

机构：

[1] CHU Montpellier, F-34090 Montpellier, France

来源：

BULLETIN DU CANCER | 2025年 / 112卷 / 05期

关键词：

Non-small cell lung cancer; EGFR mutations; Osimertinib; Chemotherapy; Oncogenic addiction;

D O I：

10.1016/j.bulcan.2025.02.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：450 / 451

页数：2

共 4 条

[1] Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions [J].

Drappier, Noemie ;

Pierret, Thomas .

BULLETIN DU CANCER, 2024, 111 (12) :1085-1087

[2] Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated EGFR [J].

Miyauchi, Eisaku ;

Morita, Satoshi ;

Nakamura, Atsushi ;

Hosomi, Yukio ;

Watanabe, Kana ;

Ikeda, Satoshi ;

Seike, Masahiro ;

Fujita, Yuka ;

Minato, Koichi ;

Ko, Ryo ;

Harada, Toshiyuki ;

Hagiwara, Koichi ;

Kobayashi, Kunihiko ;

Nukiwa, Toshihiro ;

Inoue, Akira .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) :3587-+

[3] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC [J].

Ramalingam, S. S. ;

Vansteenkiste, J. ;

Planchard, D. ;

Cho, B. C. ;

Gray, J. E. ;

Ohe, Y. ;

Zhou, C. ;

Reungwetwattana, T. ;

Cheng, Y. ;

Chewaskulyong, B. ;

Shah, R. ;

Cobo, M. ;

Lee, K. H. ;

Cheema, P. ;

Tiseo, M. ;

John, T. ;

Lin, M-C ;

Imamura, F. ;

Kurata, T. ;

Todd, A. ;

Hodge, R. ;

Saggese, M. ;

Rukazenkov, Y. ;

Soria, J-C ;

Boyer, Michael ;

Lee, Chee ;

Hughes, Brett ;

O'Byrne, Kenneth ;

Briggs, Peter ;

Milward, Michael ;

John, Thomas ;

Demedts, Ingel ;

Vansteenkiste, Johan ;

Bustin, Frederique ;

Barrios, Carlos Henrique ;

Timcheva, Constanta ;

Butts, Charles ;

Goss, Glenwood ;

Juergens, Rosalyn ;

Leighl, Natasha ;

Cheng, Susanna ;

Burkes, Ronald ;

Zhou, Caicun ;

Zhang, Helong ;

Shu, Yongqian ;

Cheng, Ying ;

Zhou, Qing ;

Li, Wei ;

Feng, Guosheng ;

He, Yong .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01) :41-50

[4] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer [J].

Soria, J. -C. ;